MDWD Stock Analysis: Buy, Sell, or Hold?
MDWD - MediWound Ltd.
$18.13
0.52 (2.95%)
▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Mar 18, 2026
Get Alerted When MDWD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MDWD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: MDWD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: MDWD is currently trading at $18.13, which is considered fair relative to its 30-day fair value range of $17.21 to $18.85.
Technical Outlook: Technically, MDWD is showing sideways momentum. Immediate support is located at $16.25, while resistance sits at $18.73.
Market Sentiment: MDWD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $31.50 (+78.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MDWD is showing sideways momentum. Immediate support is located at $16.25, while resistance sits at $18.73.
Market Sentiment: MDWD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $31.50 (+78.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$17.21 -
$18.85
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 78.9% below Wall St target ($31.50)
Fair Price Analysis
30-Day Fair Range
$17.21 -
$18.85
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$1.29
(7.1%)
Support & Resistance Levels
Support Level
$16.25
Resistance Level
$18.73
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-7.08
Wall Street Target
$31.50
(+78.9%)
Revenue Growth (YoY)
24.7%
Profit Margin
-98.4%
Last updated: January 31, 2026 12:02 AM ET
Data refreshes hourly during market hours. Next update: 1:02 AM
Data refreshes hourly during market hours. Next update: 1:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDWD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
Advanced MDWD Option Strategies
Professional options setups generated by AI based on today's MDWD price and gamma walls.
